American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Cyclerion Therapeutics, Inc. (CYCN)

$23.52 -20.94% NASDAQ: CYCN · 15-min delayed

CAMBRIDGE, Massachusetts
Public · NASDAQ: CYCN
1 employees

Visit website Follow

$15.2MMarket cap

$2.1MRevenue · FY2025

-$3.5MNet income

1Employees

CYCNNASDAQ

2019IPO

About Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: CYCN
Employees: 1
IPO date: Mar 18, 2019
Headquarters: 301 BINNEY STREET
CAMBRIDGE, Massachusetts 02142
Phone: 617-621-7722
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: CYCN Nasdaq
SEC CIK: 1755237
EIN: 831895370
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Cyclerion Therapeutics, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/cyclerion-therapeutics-inc/"><img src="https://americancompanies.com/badge/cyclerion-therapeutics-inc.svg" alt="Cyclerion Therapeutics, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Cyclerion Therapeutics, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $2.1M
Net income: -$3.5M
Total assets: $10.0M
Market cap: $15.2M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: CYCN

$23.52 -20.94%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$7.56 $44.66

52-week range

Market cap: $15.2M
Shares outstanding: 644.4K
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Mar 18, 2019

Cyclerion Therapeutics, Inc. (CYCN) Stock Price

Reported a net loss of $3.5M in FY2025.
Trading 47% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Cyclerion Therapeutics, Inc..

Write a review

Newsroom

News about Cyclerion Therapeutics, Inc.

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders GlobeNewswire Inc. · 2026-04-07 · negative Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets GlobeNewswire Inc. · 2023-07-31 Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire Inc. · 2023-06-01 Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Benzinga · 2023-05-16 Cyclerion Announces Reverse Stock Split GlobeNewswire Inc. · 2023-05-15 Cyclerion Announces Corporate Updates and Q1 2023 Financial Results GlobeNewswire Inc. · 2023-05-11

News & sentiment via Polygon.io

FAQ

Cyclerion Therapeutics, Inc.: frequently asked questions

Is Cyclerion Therapeutics, Inc. an American company?

Cyclerion Therapeutics, Inc. is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Cyclerion Therapeutics, Inc. headquartered?

Cyclerion Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

Is Cyclerion Therapeutics, Inc. publicly traded?

Yes — Cyclerion Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol CYCN on the NASDAQ.

What does Cyclerion Therapeutics, Inc. do?

Cyclerion Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore